Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly downgraded to 'Underweight' on key patent expirations and early-stage pipeline
Eli Lilly downgraded to 'Underweight' on key patent expirations and early-stage pipeline
Eli Lilly downgraded to 'Underweight' on key patent expirations and early-stage pipeline
Submitted by
admin
on September 16, 2008 - 9:39am
Source:
Yahoo/AP
Headline:
Eli Lilly downgraded to 'Underweight' on key patent expirations and early-stage pipeline
Do Not Allow Advertisers to Use My Personal information
